Abstract
Research among African-Americans indicates this population perceives sickle cell (SCD) to be a serious disease and sickle cell trait (SCT) screening an important intervention. However, studies have consistently demonstrated a lower than desired uptake of SCD education, inadequate knowledge regarding personal and family trait status, and a low perceived susceptibility of giving birth to a child with the disease. We examined general attitudes and beliefs regarding genetics and genetic testing including prenatal testing and newborn screening; we used this information as the foundation to more specifically assess attitudes and beliefs regarding SCD and perceived barriers to SCD education and awareness. Thirty-five African-American adult men and women participated in one of four focus groups. Thematic analysis identified that both prenatal testing and newborn screening are acceptable forms of genetic testing. Based largely on their personal experiences, participants possessed an understanding of the natural progression of SCD but had a limited understanding of the inheritance and probable risk of giving birth to a child with the disease. Barriers to education and greater awareness of SCD were classified as personal, familial, and societal. Community based interventions focused on sharing the stories of individuals with first-hand experiences with SCD should be considered.
Similar content being viewed by others
References
Acharya, K., Lang, C. W., & Ross, L. F. (2009). A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease. Journal of the National Medical Association, 101, 1163–1172.
Beeson, D. (1997). Nuance, complexity, and context: qualitative methods in genetic counseling research. Journal of Genetic Counseling, 6, 21–43.
BeLue, R., Taylor-Richardson, K. D., Lin, J., Rivera, A. T., & Grandison, D. (2006). African Americans and participation in clinical trials: differences in beliefs and attitudes by gender. Contemporary Clinical Trials, 27, 498–505.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.
Catz, D. S., Green, N. S., Tobin, J. N., Lloyd-Puryear, M. A., Kyler, P., Umemoto, A., et al. (2005). Attitudes about genetics in underserved, culturally diverse populations. Community Genetics, 8, 161–172.
Gullate, M. (2006). The influence of spirituality and religiosity on breast cancer screening delay in African American women: application of the Theory of Reasoned Action and Planned Behavior (TRA/TPB). Journal of the Association of Black Nursing Faculty in Higher Education, 17, 89–94.
Gustafson, S. L., Gettig, E. A., Watt-Morse, M., & Krishnamurti, L. (2007). Health beliefs among African American women regarding genetic testing and counseling for sickle cell disease. Genetics in Medicine, 9, 303–310.
Hamilton, L. A., Aliyu, M. H., Lyons, P. D., May, R., Swanson, C. L., Savage, R., et al. (2006). African-American community attitudes and perceptions toward schizophrenia and medical research: an exploratory study. Journal of the National Medical Association, 98, 18–27.
Hoyo, C., Reid, M. L., Godley, P. A., Parrish, T., Smith, L., & Gammon, M. (2003). Barriers and strategies for sustained participation of African-American men in cohort studies. Ethnicity & Disease, 13, 470–476.
Janz, N. K., & Becker, M. H. (1984). The health belief model: a decade later. Health Education Quarterly, 11, 1–47.
Kass, N. E., Medley, A. M., Natowicz, M. R., Hull, S. C., Faden, R. R., Plantinga, L., et al. (2007). Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions. American Journal of Medical Genetics. Part A, 143, 707–717.
Kessler, L., Collier, A., Brewster, K., Smith, C., Weathers, B., Wileyto, E. P., et al. (2005). Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genetics in Medicine, 7, 230–238.
King, D. F., Trouth, A. J., & Adams, A. O. (2001). Factors preventing African-Americans from seeking early intervention in the treatment of ischemic strokes. Journal of the National Medical Association, 93, 43–46.
Kladny, B., Gettig, E. A., & Krishnamurti, L. (2005). Systematic follow-up and case management of the abnormal newborn screen can improve acceptance of genetic counseling for sickle cell or other hemoglobinopathy trait. Genetics in Medicine, 7, 139–142.
Krueger, R. A., & Casey, M. A. (2000). Focus groups: A practical guide for applied research (3rd ed.). Thousand Oaks: Sage.
Laskey, S. L., Williams, J., Pierre-Louis, J., O’Riordan, M., Matthews, A., & Robin, N. H. (2003). Attitudes of African American premedical students toward genetic testing and screening. Genetics in Medicine, 5, 49–54.
Markel, H. (2006). Scientific advances and social risks: Historical perspectives of genetic screening programs for sickle cell disease, Tay-Sachs disease, neural tube. National Human Genome Research Institute. Retrieved from http://www.genome.gov/10002401.
Midence, K., Graham, V., Acheampong, C., & Okuyiga, E. (1994). Increasing awareness for higher quality care. Measuring knowledge of sickle cell disease in adult patients. Professional Nurse, 9, 255–258.
National Newborn Screening and Genetics Resource Center, National Newborn Screening Report, Sickle Carrier Program Follow-up (2009). Available at: http://nnsis.uthscsa.edu/xreports.aspx?XREPORTID=22&FORMID=8&FCLR=1. Accessed January 8, 2011.
Nicholson, W. K., Grason, H. A., & Powe, N. R. (2003). The relationship of race to women’s use of health information resources. American Journal of Obstetrics and Gynecology, 188, 580–585.
Olney, R. (2000). Newborn screening for sickle cell disease: Public health impact and evaluation. Genetics and public health in the 21st century. Oxford University. Retrieved from http://www.cdc.gov/genomics/resources/books/21stcent/chap22.htm.
Pass, K. A., Lane, P. A., Fernhoff, P. M., Hinton, C. F., Panny, S. R., Parks, J. S., et al. (2000). US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council for Regional Networks for Genetic Services (CORN). Journal of Pediatrics, 137, S1–S46.
Richardson, J. T., Webster, J. D., & Fields, N. J. (2004). Uncovering myths and transforming realities among low-SES African-American men: implications for reducing prostate cancer disparities. Journal of the National Medical Association, 96, 1295–1301.
Richer, J., & Chudley, A. E. (2005). The hemoglobinopathies and malaria. Clinical Genetics, 68, 332–336.
Robins, A. G. (2005). Surveillance of selected chronic diseases: Benchmarks for the healthy Black Family Project. Allegheny Health Department and Center for Minority Health.
Rucker-Whitaker, C., Flynn, K. J., Kravitz, G., Eaton, C., Calvin, J. E., & Powell, L. H. (2006). Understanding African-American participation in a behavioral intervention: results from focus groups. Contemporary Clinical Trials, 27, 274–286.
Sandelowski, M. (2000). Focus on research methods: whatever happened to qualitative description? Research in Nursing and Health, 23, 334–340.
Talosig-Garcia, M., & Davis, S. W. (2005). Information-seeking behavior of minority breast cancer patients: an exploratory study. Journal of Health Communication, 10, 53–64.
The New York State Task Force on Life and the Law. (2000). Genetic testing and screening in the age of genomic medicine. New York: Author.
Thomas, S., & Quinn, S. (2008). Poverty and the elimination of urban health disparities: challenge and opportunity. Annals of the New York Academy of Sciences, 1136, 111–125.
Treadwell, M. J., McClough, L., & Vichinsky, E. (2006). Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. Journal of the National Medical Association, 98, 704–710.
US Census Bureau (2005). Poverty thresholds. Available at: http://www.census.gov/hhes/www/poverty/data/threshld/thresh05.html. Accessed January 30, 2011.
Vogel, K. J., Murthy, V. S., Dudley, B., Grubs, R. E., Gettig, E., Ford, A., et al. (2007). The use of family health histories to address health disparities in an African American community. Health Promotion Practice, 8, 350–357.
Wethers, D. L. (2000a). Sickle cell disease in childhood: part I. Laboratory diagnosis, pathophysiology, and health maintenance. American Family Physician, 62, 1013–1020.
Wethers, D. L. (2000b). Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment. American Family Physician, 62, 1309–1314.
Wilson, R. E., Krishnamurti, L., & Kamat, D. (2003). Management of sickle cell disease in primary care. Clinical Pediatrics, 42, 753–761.
Wright, S. W., Zeldin, M. H., Wrenn, K., & Miller, O. (1994). Screening for sickle-cell trait in the emergency department. Journal of General Internal Medicine, 9, 421–424.
Zimmerman, R. K., Tabbarah, M., Nowalk, M. P., Raymund, M., Jewell, I. K., Wilson, S. A., et al. (2006). Racial differences in beliefs about genetic screening among patients at inner-city neighborhood health centers. Journal of the National Medical Association, 98, 370–377.
Acknowledgements
This study was completed in partial fulfillment of the requirements for the first author’s Master of Science degree from the University of Pittsburgh. We are grateful for the financial resources to complete this project provided by the University of Pittsburgh Center for Minority Health, NIH National Institute on Minority Health and Health Disparities (PG60MD000207; S. Thomas, PI), and the Sickle Cell Program at Children’s Hospital of Pittsburgh.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
We thank you for participating in this focus group. This survey is to gather information about the community’s interactions with genetics, genetic testing, and sickle cell. If there is a question that you do not feel comfortable answering, you can skip it and continue on. Please answer the following questions to the best of your ability. The survey should take approximately 10 minutes. We would like to thank you in advance for your willingness to participate in this study.
Section 1: General Information
-
1)
What is your age?
__ __ age in years
-
2)
What is your gender?
-
1
Male
-
2
Female
-
1
-
3)
Are you Hispanic or Latino?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
-
3a)
Which one or more of the following would you say is your race? (Check all that apply)
-
1
White
-
2
Black or African American
-
3
Asian
-
4
Native Hawaiian or Other Pacific Islander
-
5
American Indian, Alaska Native
-
6
Other [specify] __________________________
-
1
-
4)
What was the total household income from all sources last year?
-
1
Less than $10,000
-
2
Between $10,000 and $20,000
-
3
Between $20,001 and $35,000
-
4
Between $35,001 and $50,000
-
5
Between $50,001 and $75,000
-
6
Greater than $75,000
-
1
-
5)
What is the highest grade or year of school you completed?
-
1
Grades 8 or less (Elementary)
-
2
Grades 9 through 11 (Some high school)
-
3
Grade 12 or GED (High school graduate)
-
4
College 1 year to 3 years (Some college or technical school)
-
5
College 4 years or more (College graduate or post-graduate)
-
6
Graduate level (Masters or PhD)
-
1
-
6)
How would you rate your knowledge on genetics?
-
1
Excellent
-
2
Very good
-
3
Good
-
4
Fair
-
5
Poor
-
1
-
7)
How would you describe your general health?
-
1
Excellent
-
2
Very good
-
3
Good
-
4
Fair
-
5
Poor
-
1
-
8)
Do you smoke?
-
1
Yes
-
2
No
-
1
-
9)
How would you describe your weight?
-
1
Underweight
-
2
Healthy weight
-
3
Overweight
-
4
Obese
-
1
-
10)
Do you have one person you think of as your personal doctor or health care provider?
-
1
Yes, only one
-
2
More than one
-
3
No
-
4
Don’t know / Not sure
-
1
-
11)
Was there a time in the past 12 months when you needed to see a doctor but could not because of the cost?
-
1
1 Yes
-
2
No
-
3
Don’t know / Not sure
-
1
-
12)
Do you have any kind of health care coverage, including health insurance, prepaid plans such as HMOs, or government plans such as Medicare?
-
1
Yes
-
2
No
-
3
Don’t know / Not sure
-
1
Section 2: Sickle Cell and Newborn Screening
-
13)
Do you know your sickle cell trait status?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
-
14)
Do you know your partner/spouse’s sickle cell trait status?
-
1
Yes
-
2
No
-
3
Don’t know
-
4
Not applicable
-
1
-
15)
Do you have children?
-
1
Yes
-
2
No
-
1
-
16)
If you answered “Yes” to the previous question, do you know your child’s sickle cell trait status?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
-
17)
Do you know someone with sickle cell disease?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
-
18)
Do you know someone with sickle cell trait?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
-
19)
Do you know someone that was found to have sickle cell disease or trait by newborn screening?
-
1
Yes
-
2
No
-
3
Don’t know
-
1
Focus Group Guide
-
I.
Introduction (10 min)
Good afternoon/evening and welcome to our session. Thank you for taking the time to join our discussion on genetics, genetic testing, and sickle cell. My name is ____ and I am with the Healthy Black Family Project from the Center for Minority Health at the University of Pittsburgh. Assisting me is _____ who will be taking notes on the conversation during the focus group. Please begin by filling out the survey in front of you by circling your answers. We will begin when everyone has completed this form.
You have been invited because you are a member of the Healthy Black Family Project and your opinions on genetics, genetic testing, and sickle cell are important to us. Our research team is trying to understand the attitudes and beliefs of African-Americans toward these issues. We would like to hear your opinions. We will ask you a number of questions and we need your honest thoughts and ideas. Please feel free to share your point of view especially if it is different from what others have said. There are no wrong answers, only different points of view.
Now, let me share some ground rules. We want to make sure that everyone feels comfortable expressing his or her own opinion. We ask that you are respectful of everyone by listening to one another and waiting until the person speaking has finished before you begin. Please do not have side conversations with your neighbor during the discussion. All of your comments are helpful and would provide us with useful information. We have placed cards on the table in front of you to help us remember your names during the focus group.
As you have probably noticed, we have a microphone on the table. We will be tape recording our discussion so that we don’t miss any of your comments. To assure you of your confidentiality, we will only be using the names you selected for today and will not use any names in our final reports.
The group discussion will last about 2 hours so please feel free to enjoy your meal as we begin. We will have a 10-minute break. You should have already completed the brief survey and we will collect it before we begin.
-
II.
Assessing Knowledge of Genetics
Question 1
-
Where do you receive trusted medical information?
-
Probe: From a Physician, Nurse, Pharmacist, Friend/Family member, TV, radio, newspaper, internet, seminar, etc.?
-
Probe: Why is this your most trusted source of medical information?
-
Question 2
-
What comes to mind when you hear the word “genetic” or “genetics”?
-
Probe: Where have you heard this word? Who has used the word?
-
Probe: How do you think “things” are passed down to or inherited from one generation to another? Why?
-
-
-
III.
Assessing Knowledge of Prenatal Testing and Newborn Screening for Genetic Conditions
Question 3
-
When you hear the words “prenatal testing” what does it mean to you?
[Definition shared if no one answers: Prenatal testing is testing performed on the developing baby while a woman is pregnant. It can be used to gather information about genetic health conditions in the baby.]
-
Probe: Are there benefits of prenatal testing? What are these benefits? Why?
-
Probe: Are there risks of prenatal testing? What are these risks? Why?
-
Probe: Would you want to know if your baby had a genetic condition?
-
Question 4
-
When you hear the phrase “newborn screening” what do you think of?
-
Probe: This is also referred to as the “heel stick test.”
[Definition shared if no one answers: Newborn screening is testing performed on the newborn baby before leaving the hospital. A small sample of blood is obtained from the baby’s heel to test for rare genetic diseases that are life-threatening but where early intervention or treatment has an impact on disease outcome.]
-
Probe: Where have you heard the phrase used?
-
Probe: Who has used it?
-
Probe: Under what conditions or circumstances has it been used?
-
Probe: What kind of information would you like to know before a child’s blood is taken?
-
Probe: Are there benefits of newborn screening? What are these benefits? Why?
-
Probe: Are there risks of newborn screening? What are these risks? Why?
-
Probe: Would you want to know if your child had a genetic condition?
-
-
-
IV.
Assessing Understanding of Sickle Cell Disease
Question 5
-
What is sickle cell disease?
-
Probe: Where have you heard this condition discussed?
-
Probe: What is the difference between the sickle cell disease and sickle cell trait?
-
Probe: Do you think one is more serious than the other? Why?
-
Probe: How does someone get sickle cell?
-
-
-
V.
Assessing Perceived Risk of Sickle Cell
Question 6
-
Earlier we talked about how things are inherited or genetics, do you think there is a risk in your family to have a future child or grandchild with sickle cell trait? Do you think there is a risk in your family to have a future child or grandchild with sickle cell disease?
-
Probe: Why or why not?
-
-
-
VI.
Assessing Opinions on Sickle Cell and Newborn Screening
Question 7
-
Scenario: It is three days after the birth of your child and you just found out your child has sickle cell disease. How helpful would this information be to you?
-
If your child had sickle cell trait, how helpful would this information be to you?
-
Probe: What would you do with this information?
-
-
-
VII.
Assessing Ideas on Community Education Interventions
Question 8
-
How can the community help parents become more aware of information about sickle cell?
-
-
VIII.
Closing
Thank you for your time and energy given to this discussion. It was a pleasure listening to your thoughts and opinions. We will need your signature to indicate you have received your $25 gift certificate before you leave.
Rights and permissions
About this article
Cite this article
Long, K.A., Thomas, S.B., Grubs, R.E. et al. Attitudes and Beliefs of African-Americans Toward Genetics, Genetic Testing, and Sickle Cell Disease Education and Awareness. J Genet Counsel 20, 572–592 (2011). https://doi.org/10.1007/s10897-011-9388-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-011-9388-3